FDA Leaders’ Public Health Fundamentals Offer Hope To Sponsors

FDA wants to be judged on its overall impact on public health - not on drug approvals - Commissioner Peggy Hamburg and Principal Deputy Josh Sharfstein say in the New England Journal of Medicine